DIRS.INFO The most relevant business & tech news

Following Thursday's trade, Jim Cramer's Charitable Trust will own 2,930 shares of BHC, decreasing its weighting in the portfolio to 0.82% from 1.1%. We're trimming roughly one-quarter of our Bausch Health position to manage our downside risk ahead of a key event. As the likelihood of monetizing its BLCO stake increases, BHC shares are expected to trade appreciably higher. BHC 1Y mountain Bausch Health Companies 1 year What we have on our hands is a binary situation and the outcome could go either way. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Jim Cramer's, Xifaxan, Bausch, Jefferies, BHC, Johnson, haven't, we've, It's, Jim Cramer, Jim Organizations: Bausch Health, Jefferies, Health, CNBC

☆ Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million
▼ + stars: | 2024-01-23 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California. Johnson & Johnson has reached a tentative settlement to resolve an investigation by more than 40 states into claims the company misled patients about the safety of its talc baby powder and other talc-based products, the company said in a statement to CNBC on Tuesday. Those cases have for decades caused financial and public relations trouble for J&J, which contends that its talc-based products and now-discontinued talc baby powder are safe for consumers. J&J said in an October securities filing that 42 states and Washington, D.C., had launched a joint investigation into its marketing of talc-based products. The company will pay $700 million to settle the probe, its CFO Joseph Wolk told The Wall Street Journal on Tuesday.

Persons: Johnson, J, Joseph Wolk Organizations: Johnson, CNBC, D.C, Wall Locations: San Anselmo , California, Washington

☆ Lightning Round: I would own Clorox, says Jim Cramer
▼ + stars: | 2023-11-07 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: I would own Clorox, says Jim Cramer'Mad Money' host Jim Cramer weighs in on stocks including: Clorox, AGNC, Cisco, Johnson and Johnson and Ventas.

Persons: Jim Cramer, Johnson Organizations: Cisco, Johnson

☆ J&J's Janssen to close part of its vaccine division -Telegraaf
▼ + stars: | 2023-08-23 | by ( ) www.reuters.com time to read: +2 min

[1/2] The exterior of Johnson and Johnson's subsidiary Janssen Vaccines in Leiden, Netherlands, March 9, 2021. REUTERS/Piroschka van de Wouw Acquire Licensing RightsAMSTERDAM, Aug 23 (Reuters) - Johnson & Johnson's (JNJ.N) Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported. In an emailed response on Wednesday, Johnson & Johnson confirmed plans to exit some of its vaccine research and development programmes, which it said it had initially disclosed in its 2023 second-quarter results. De Telegraaf reported that 2,500 people worked at Janssen in the Netherlands, a quarter of which were in the section specialising in infectious diseases and vaccines. J&J's relatively large Dutch vaccine operation stems in part from its $2.1 billion acquisition in 2011 of vaccine maker Crucell.

Persons: Johnson, de Wouw, Janssen, De Telegraaf, J, Charlotte Van Campenhout, Toby Sterling, David Goodman, David Evans Organizations: Janssen Vaccines, REUTERS, Rights, Thomson Locations: Leiden, Netherlands

Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 19, 2023. The S&P 500 information technology sector (.SPLRCT), which houses Nvidia, rose 0.7% while real estate (.SPLRCR) and utilities (.SPLRCU) were a drag, down more than 1% each. Declining issues outnumbered advancers by a 2.38-to-1 ratio on the NYSE and a 1.46-to-1 ratio on the Nasdaq. The S&P index recorded one new 52-week high and 18 new lows, while the Nasdaq recorded 27 new highs and 141 new lows. Reporting by Amruta Khandekar and Shristi Achar; Editing by Arun Koyyur and Vinay DwivediOur Standards: The Thomson Reuters Trust Principles.

Persons: Brendan McDermid, Thomas Hayes, Jerome Powell, stokes, Dow, Johnson, Goldman Sachs, Amruta Khandekar, Arun Koyyur, Vinay Dwivedi Organizations: New York Stock Exchange, REUTERS, Palo Alto Networks, Broadcom Indexes, Dow, Nasdaq, Nvidia, HSBC, Fed, Great, Capital LLC, Equity Research, Dow Jones, Federal, Federal Reserve, Traders, Reuters Graphics Reuters, VMware, NYSE, Thomson Locations: New York City, U.S, Jackson, Wyoming

A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016. LTL's bankruptcy proceedings have largely paused the 38,000 lawsuits against J&J, although one case was allowed to proceed to a $18.8 million verdict in July. But David Molton, an attorney for the official committee representing cancer claimants in LTL's bankruptcy, said that a temporary prohibition on new bankruptcy filings was appropriate, given LTL's repeated bankruptcy filings. Kaplan, who dismissed LTL's second bankruptcy, said he was not inclined to block future bankruptcy filings because circumstances could change in the next six months. But the judge said he was open to further written arguments on that point before issuing a formal decision closing LTL's second bankruptcy case next week.

Persons: Johnson, Mike Segar, J, Michael Kaplan, Greg Gordon, David Molton, Kaplan, LTL's, J's, Dietrich Knauth, Cynthia Osterman Organizations: REUTERS, Johnson, LTL Management, U.S . Department of, J, Thomson Locations: New York, Trenton , New Jersey, LTL's, Texas

U.S. Bankruptcy Judge Michael Kaplan in Trenton, New Jersey, ruled that a J&J company's second bankruptcy, like its first, must be dismissed because the talc lawsuits did not put it in immediate "financial distress." J&J's first bankruptcy gambit began in 2021, when it offloaded its talc liabilities into a new company, LTL Management, and immediately placed that company into bankruptcy. Attorneys representing cancer victims, along with the U.S. Justice Department's bankruptcy watchdog, had called for LTL's second bankruptcy to be dismissed as an abuse of U.S. bankruptcy law. Andy Birchfield, an attorney who represents cancer victims, said the second bankruptcy was meant to keep the talc lawsuits from being heard by juries. J&J argued that the proposed bankruptcy settlement offers a fairer and faster resolution for cancer claimants than litigation in other courts.

Persons: Johnson, Mike Segar, imperiling, Michael Kaplan, J, Kaplan, J's, LTL's, LTL, U.S . Justice Department's, Andy Birchfield, Birchfield, Dietrich Knauth, Mike Spector, Jonathan Oatis, Matthew Lewis, Leslie Adler Organizations: REUTERS, Johnson, LTL Management, U.S . Justice, J, Thomson Locations: New York, U.S, Trenton , New Jersey, California

☆ Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time
▼ + stars: | 2023-07-28 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California. A federal bankruptcy judge on Friday rejected Johnson & Johnson 's second attempt to resolve tens of thousands of lawsuits alleging the company's talc baby powder and other talc-based products caused cancer. J&J in 2021 offloaded those talc liabilities into a new subsidiary, LTL Management, and immediately filed for Chapter 11 bankruptcy protections. "LTL commenced its bankruptcy case in good faith and in strict compliance with the Bankruptcy Code," J&J said in a statement. J&J contends that research and clinical evidence demonstrates that its talc products remain safe.

Persons: Johnson, Michael Kaplan, LTL, J's, J, Erik Haas Organizations: LTL Management Locations: San Anselmo , California, Trenton , New Jersey

☆ Here's what Jim Cramer thinks about J&J stock after a pivotal talc case verdict
▼ + stars: | 2023-07-21 | by ( Paulina Likos | ) www.cnbc.com time to read: +7 min

But on Tuesday, J & J was ordered to pay $18.8 million after jurors found in favor of 24-year-old Emory Hernandez Valadez who claimed in his lawsuit that he developed mesothelioma, a deadly cancer linked to asbestos, from exposure to J & J talc products. J & J has said that over 60,000 claimants support its latest $8.9 billion settlement to be paid out over 25 years. Johnson & Johnson issued an official statement following the verdict in favor of Valdez, intending to appeal. Even so, J & J got a few of price target increases on Wall Street on Friday. The higher growth pharmaceuticals and medical technology businesses are remaining as the new J & J.

Persons: Johnson, J's, Jim Cramer, Jim, J, Emory Hernandez Valadez, we're, there's, Moshe Maimon, Levy, Maimon, Michael Kaplan, Kaplan, Erik Haas, Thursday's, Haas, Jim Cramer's, Justin Sullivan Organizations: Johnson, LTL Management, J, Credit Suisse, AAA, CNBC, & ' $, & $ Locations: California, American, Levy Konigsberg, Valdez, Stifel, Kenvue, San Anselmo , California

☆ Jurors urged to impose heavy punitive damages in J&J talc trial
▼ + stars: | 2023-07-10 | by ( Brendan Pierson | ) www.reuters.com time to read: +3 min

J&J has consistently denied that its now-discontinued talc baby powder contains asbestos or causes cancer. Satterley asked jurors to award Hernandez punitive damages about nine times greater than so-called compensatory damages, which include $3.8 million for his medical costs as well as damages for pain and suffering. The U.S. Supreme Court has found that punitive damages should generally be no more than nine times compensatory damages, and that a higher ratio can be reduced on appeal as excessive. J&J has said its talc products are safe and do not contain asbestos, which has been linked to mesothelioma. J&J said in bankruptcy court filings that the costs of its talc-related verdicts, settlements and legal fees have reached about $4.5 billion.

Persons: Johnson, Mike Segar, ” Joseph Satterley, Emory Hernandez Valadez, Satterley, Hernandez, Allison Brown, “, Michael Kaplan, LTL, J Organizations: Reuters, REUTERS, Alameda County Superior Court, U.S, Supreme, LTL Management, LTL’s Locations: California, Johnson, New York, Alameda County, Trenton , New Jersey

Hong Kong CNN —US drugmaker Moderna has signed a deal to make mRNA medicines in China as part of its first major investment in the country, despite escalating trade and political tension between Washington and Beijing. The company currently only markets its mRNA vaccines for Covid-19, but has a number of vaccines and therapeutics in its pipeline. Those focus on addressing infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases, according to the company. Moderna’s Covid-19 vaccine, which received emergency authorization from US regulators in 2020 and full approval in 2022, has not been approved in China. For most of the pandemic, China relied on more traditional platforms for its homegrown Covid-19 vaccines.

Persons: Yicai, Janet Yellen, Biden, Moderna’s, Johnson Organizations: Hong Kong CNN, CNN, Xinhua, CSPC Pharmaceutical Group, Pfizer Locations: Hong Kong, China, Washington, Beijing, The Cambridge , Massachusetts, Shanghai’s Minhang, Shijiazhuang

☆ Sales, spins and splits — what are the differences and why do they matter for investors like us?
▼ + stars: | 2023-04-30 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +20 min

Investors may get one share in the spun-out entity for every share of the parent company they owned. What's left of J & J will be focused on pharmaceuticals and medical technologies, which were responsible for over 84% of the company's total 2022 revenue of $94.94 billion. It underscores that once free of the parent company tethers a divested company can chart its own destiny. Those priorities may not have necessarily been wrong when considering J & J as the overall enterprise. We believe J & J and Danaher are poised to deliver two more examples.

☆ These 11 Club stocks have boosted their dividend payouts this year. Here's a list and who's next
▼ + stars: | 2023-04-21 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +4 min

Johnson & Johnson (JNJ) and Costco Wholesale (COST) became the latest Club holdings to hike their payouts this week, bringing the year-to-date total to 11. Cisco Systems (CSCO), meanwhile, raised its dividend by a more modest 2.6%, to 39 cents a share, from 38 cents. Here is the full list of the Club stocks that have raised their dividends this year. In the case of these 11 Club holdings, the dividend increases are favorable developments, even if the magnitude varies from company to company. It is no surprise Johnson & Johnson, Procter & Gamble (PG) — which delivered a quarterly earnings beat Friday — and Linde (LIN) have raised their dividend already this year.

☆ U.S. bankruptcy judge halts 40,000 Johnson & Johnson talc and cancer lawsuits
▼ + stars: | 2023-04-20 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California. A federal bankruptcy judge on Thursday halted roughly 40,000 lawsuits that allege Johnson & Johnson 's baby powder and other talc products caused cancer. Amid the ongoing legal fights, J&J has continued to deny the allegations that its talc products caused cancer. The suits allege J&J's talc products were contaminated with the carcinogen asbestos, which caused ovarian cancer in thousands of individuals. Some lawsuits link several deaths to J&J's talc products.

Their stocks average a gain of at least 0.5% on earnings day. The companies have also beaten analysts' expectations at least 75% of the time over five years. Johnson & Johnson has been in the news in recent weeks after settling a lawsuit over claims that the company's baby powder and other talc products caused cancer for $8.9 billion. Historically, the stock has gained 0.78% on earnings day, but what's more impressive is the company's average five-year beat rate of 100%. The bank has beaten analysts' expectations 85% of the time in five years.

☆ J&J rises as $9 bln talc lawsuit settlement eases overhang on unit spinoff
▼ + stars: | 2023-04-05 | by ( ) www.reuters.com time to read: +2 min

[1/2] A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016. Some analysts were positive about the new settlement that is far bigger than the original offer of $2 billion, as they believe it could bring an end to the lawsuit. J.P. Morgan analyst Chris Schott said in a note the settlement amount was in-line with the brokerage's estimate of $8 billion to $10 billion. "We believe today's announcement should help the IPO of 20% of the consumer unit," Credit Suisse analyst Trung Huynh said in a note. "Overall, we believe the proposed settlement has vast support by the plaintiff supermajority and the top 18 law firms representing the claimants," Jennings said.

☆ J&J rises as $8.9 bln talc lawsuit settlement eases overhang on consumer unit spinoff
▼ + stars: | 2023-04-05 | by ( ) www.reuters.com time to read: +2 min

☆ Exclusive: Johnson & Johnson considers refiling talc-liability bankruptcy after appeals-court defeat
▼ + stars: | 2023-04-04 | by ( Mike Spector | Thomson Reuters | Mike Spector Is A Correspondent At Reuters Covering Corporate Crises That Span Bankruptcy | ) www.reuters.com time to read: +8 min

[1/2] A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016. In a court filing Tuesday, lawyers representing a creditors committee of talc plaintiffs said they recently became aware of discussions about a second J&J subsidiary bankruptcy. The J&J subsidiary that was to absorb liability for the talc cases, LTL Management, declared bankruptcy almost immediately after it was created. Andy Birchfield, a plaintiffs' lawyer at law firm Beasley Allen, said on Tuesday that claims “could easily be resolved if Johnson & Johnson would stop playing games and abusing the bankruptcy court process." How the J&J subsidiary might square such a move with the appeals court ruling remained unclear.

☆ J&J will pay $8.9 billion to settle claims cosmetic talc products caused cancer
▼ + stars: | 2023-04-04 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Containers of Johnson's baby powder made by Johnson and Johnson are displayed on a shelf on July 13, 2018 in San Francisco, California. Johnson & Johnson on Tuesday said it will pay $8.9 billion over the next 25 years to settle allegations that the company's baby powder and other talc products caused cancer. The company ended sales of its talc-based baby powder globally in 2023 after it faced thousands of lawsuits from customers claiming its talc products caused cancer due to contamination with a carcinogen called asbestos. J&J spun off subsidiary LTL management in October 2021 in a bid to reduce its losses from litigation and settlement. The company funneled its talc lawsuits to the subsidiary and declared it bankrupt.

☆ Appeals court dismisses Johnson and Johnson talc bankruptcy case
▼ + stars: | 2023-01-30 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAppeals court dismisses Johnson and Johnson talc bankruptcy caseCNBC's Meg Tirrell joins 'Halftime Report' to report on the U.S. appeals court decision to toss out Johnson and Johnson's talc powder settlements in to a bankruptcy case, the reasons behind the ruling, and the next steps for J&J.

☆ Earnings could keep the market on edge in week ahead as investors wait for Fed
▼ + stars: | 2023-01-20 | by ( Patti Domm | In | ) www.cnbc.com time to read: +8 min

I do think that will happen even more in the week ahead as the Fed is in a blackout period. S & P Global PMI data is released for both services and manufacturing Tuesday. "The market continues to think the Fed does not have to administer as much medicine as the Fed tells us they plan to. Earnings, earnings, earnings Stocks were lower in the past week, with the S & P 500 off by 1.8%. "It's a mild earnings recession, but it's an earnings recession.

☆ Here's the exclusive 12-slide pitch deck medical cybersecurity startup MedCrypt used to nab $25 million in funding from Johnson and Johnson
▼ + stars: | 2022-11-01 | by ( Samantha Stokes | ) www.businessinsider.com time to read: +2 min

Healthcare cybersecurity startup MedCrypt just raised $25 million in Series B funding. Here's the pitch deck used to woo investors at Intuitive Ventures and Johnson & Johnson Innovation. Healthcare cybersecurity startup MedCrypt just raised a $25 million Series B, Insider has learned. Intuitive Ventures and Johnson & Johnson Innovation led the round, while Section 32, Erica Ventures, Anzu Partners, and Dolby Family Ventures also participated. Last year, competitors including New York-based healthcare cybersecurity startup Cylera raised a $10 million Series A, while Israeli IOT cybersecurity startup Cynerio raised $30 million in Series B funding.

☆ Cramer’s Mad Dash: Johnson & Johnson
▼ + stars: | 2022-10-18 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCramer’s Mad Dash: Johnson & JohnsonCNBC’s Jim Cramer joins ‘Squawk on the Street’ to discuss Johnson and Johnson ahead of the opening bell.

☆ DCLA's Sarat Sethi weighs in on earnings for J&J and expectations for Goldman Sachs
▼ + stars: | 2022-10-18 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDCLA's Sarat Sethi weighs in on earnings for J&J and expectations for Goldman SachsSarat Sethi, DCLA portfolio manager, joins 'Squawk Box' to discuss earnings season for Johnson and Johnson and Goldman Sachs.

☆ Stocks are giving some clues that there could be a Republican congressional sweep, Strategas says
▼ + stars: | 2022-10-15 | by ( Patti Domm | In | ) www.cnbc.com time to read: +7 min

At the same time, odds for a Republican sweep on Nov. 8 have risen. Individual solar and other renewable names are also down sharply, like First Solar, which is in the Strategas Democratic portfolio. Clifton said his portfolios are pointing to a 60% chance of a Republican sweep, while betting markets are at 50/50. Among the holdings in the Republican portfolio are companies that would benefit from distribution and transportation of oil and gas, like Enterprise Products Partners. "The market is increasingly pricing in a Republican sweep.

Search resuls for: "Johnson and Johnson"

25 mentions found